CST6 is induced subsequently to serine/threonine-protein kinase B-Raf (BRAF) activation and therefore may be downstream in the BRAF/MEK (mitogen-activated protein kinase kinase)/extracellular signal-regulated kinase signaling pathway in papillary thyroid carcinoma (PTC) [120]. This evidence concerns the gene BRAF and differentiated thyroid carcinoma.